Pacira BioSciences Book Value Per Share Growth & History (PCRX)
Pacira BioSciences's book value per share was $16.86 for fiscal 2025.
View full Pacira BioSciences company overviewPacira BioSciences annual book value per share history
| Fiscal year | Period ended | Book value per share | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $16.86 | $0.02 | +0.15% |
| 2024 | 2024-12-31 | $16.83 | -$1.89 | −10.08% |
| 2023 | 2023-12-31 | $18.72 | $1.85 | +10.94% |
| 2022 | 2022-12-31 | $16.87 | $0.55 | +3.35% |
| 2021 | 2021-12-31 | $16.33 | $2.13 | +14.98% |
| 2020 | 2020-12-31 | $14.20 | $5.73 | +67.67% |
| 2019 | 2019-12-31 | $8.47 | $0.68 | +8.69% |
| 2018 | 2018-12-31 | $7.79 | $0.92 | +13.39% |
| 2017 | 2017-12-31 | $6.87 | $1.03 | +17.63% |
| 2016 | 2016-12-31 | $5.84 | -$0.08 | −1.42% |
| 2015 | 2015-12-31 | $5.93 | $1.19 | +25.19% |
| 2014 | 2014-12-31 | $4.73 | $3.51 | +286.05% |
| 2013 | 2013-12-31 | $1.23 | -$0.79 | −39.25% |
| 2012 | 2012-12-31 | $2.02 | $0.11 | +5.97% |
| 2011 | 2011-12-31 | $1.90 | $86.20 | — |
| 2010 | 2010-12-31 | -$84.30 | -$44.25 | — |
| 2009 | 2009-12-31 | -$40.04 | — | — |
Pacira BioSciences quarterly book value per share
| Fiscal quarter | Period ended | Book value per share | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $16.87 | -$0.00 | −0.02% |
| Q1 2026 | 2026-03-31 | $16.63 | -$0.62 | −3.59% |
| Q4 2025 | 2025-12-31 | $16.86 | $0.02 | +0.15% |
| Q3 2025 | 2025-09-30 | $16.93 | $0.68 | +4.20% |
| Q2 2025 | 2025-06-30 | $16.88 | -$2.19 | −11.48% |
| Q1 2025 | 2025-03-31 | $17.25 | -$1.93 | −10.04% |
| Q4 2024 | 2024-12-31 | $16.83 | -$1.89 | −10.08% |
| Q3 2024 | 2024-09-30 | $16.24 | -$1.67 | −9.31% |
| Q2 2024 | 2024-06-30 | $19.07 | $1.66 | +9.51% |
| Q1 2024 | 2024-03-31 | $19.18 | $2.47 | +14.79% |
| Q4 2023 | 2023-12-31 | $18.72 | $1.85 | +10.94% |
| Q3 2023 | 2023-09-30 | $17.91 | $1.12 | +6.67% |
| Q2 2023 | 2023-06-30 | $17.41 | $0.89 | +5.39% |
| Q1 2023 | 2023-03-31 | $16.71 | $0.96 | +6.11% |
| Q4 2022 | 2022-12-31 | $16.87 | $0.55 | +3.35% |
| Q3 2022 | 2022-09-30 | $16.79 | $0.65 | +4.04% |
| Q2 2022 | 2022-06-30 | $16.52 | $1.06 | +6.83% |
| Q1 2022 | 2022-03-31 | $15.75 | $0.94 | +6.35% |
| Q4 2021 | 2021-12-31 | $16.33 | $2.13 | +14.98% |
| Q3 2021 | 2021-09-30 | $16.14 | $2.64 | +19.56% |
| Q2 2021 | 2021-06-30 | $15.46 | $6.35 | +69.75% |
| Q1 2021 | 2021-03-31 | $14.81 | $5.92 | +66.71% |
| Q4 2020 | 2020-12-31 | $14.20 | $5.73 | +67.67% |
| Q3 2020 | 2020-09-30 | $13.50 | $5.20 | +62.62% |
| Q2 2020 | 2020-06-30 | $9.11 | $0.90 | +10.94% |
| Q1 2020 | 2020-03-31 | $8.88 | $0.95 | +11.96% |
| Q4 2019 | 2019-12-31 | $8.47 | $0.68 | +8.69% |
| Q3 2019 | 2019-09-30 | $8.30 | $0.96 | +13.14% |
| Q2 2019 | 2019-06-30 | $8.21 | $1.12 | +15.76% |
| Q1 2019 | 2019-03-31 | $7.93 | $1.09 | +15.97% |
| Q4 2018 | 2018-12-31 | $7.79 | $0.92 | +13.39% |
| Q3 2018 | 2018-09-30 | $7.34 | $0.81 | +12.40% |
| Q2 2018 | 2018-06-30 | $7.09 | $0.62 | +9.56% |
| Q1 2018 | 2018-03-31 | $6.84 | $0.08 | +1.15% |
| Q4 2017 | 2017-12-31 | $6.87 | $1.03 | +17.63% |
| Q3 2017 | 2017-09-30 | $6.53 | $0.78 | +13.62% |
| Q2 2017 | 2017-06-30 | $6.47 | $0.35 | +5.69% |
| Q1 2017 | 2017-03-31 | $6.76 | $0.67 | +10.93% |
| Q4 2016 | 2016-12-31 | $5.84 | -$0.08 | −1.42% |
| Q3 2016 | 2016-09-30 | $5.75 | $0.06 | +0.98% |
| Q2 2016 | 2016-06-30 | $6.13 | $0.79 | +14.85% |
| Q1 2016 | 2016-03-31 | $6.10 | $1.03 | +20.39% |
| Q4 2015 | 2015-12-31 | $5.93 | $1.19 | +25.19% |
| Q3 2015 | 2015-09-30 | $5.69 | $1.38 | +32.16% |
| Q2 2015 | 2015-06-30 | $5.33 | $1.21 | +29.19% |
| Q1 2015 | 2015-03-31 | $5.06 | $4.01 | +379.27% |
| Q4 2014 | 2014-12-31 | $4.73 | $3.51 | +286.05% |
| Q3 2014 | 2014-09-30 | $4.30 | $2.84 | +193.73% |
| Q2 2014 | 2014-06-30 | $4.13 | $2.35 | +131.99% |
| Q1 2014 | 2014-03-31 | $1.06 | -$1.06 | −50.11% |
| Q4 2013 | 2013-12-31 | $1.23 | -$0.79 | −39.25% |
| Q3 2013 | 2013-09-30 | $1.47 | -$1.01 | −40.82% |
| Q2 2013 | 2013-06-30 | $1.78 | -$1.14 | −38.94% |
| Q1 2013 | 2013-03-31 | $2.12 | $0.65 | +44.50% |
| Q4 2012 | 2012-12-31 | $2.02 | $0.11 | +5.97% |
| Q3 2012 | 2012-09-30 | $2.48 | $1.67 | +207.52% |
| Q2 2012 | 2012-06-30 | $2.92 | $1.58 | +119.04% |
| Q1 2012 | 2012-03-31 | $1.47 | — | — |
| Q4 2011 | 2011-12-31 | $1.90 | $86.20 | — |
| Q3 2011 | 2011-09-30 | $0.81 | — | — |
| Q2 2011 | 2011-06-30 | $1.33 | — | — |
| Q4 2010 | 2010-12-31 | -$84.30 | — | — |
Pacira BioSciences book value per share trends
Over the last five fiscal years, Pacira BioSciences's book value per share increased from $14.20 to $16.86, a change of $2.66. The latest reported quarter, Q2 2026, shows $16.87.
What book value per share means
Book value per share estimates the common shareholders’ accounting equity represented by each share. It can help compare a company’s balance-sheet value over time, although market value can differ substantially from book value.
How book value per share is calculated
TickerStat calculates book value per share as SEC-reported common shareholders’ equity divided by reported period-end common shares. Preferred equity is subtracted when separately reported, and basic weighted-average shares are used only when period-end shares are unavailable. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Pacira BioSciences source filings ↗